Naturally Splendid (TSXV:NSP) announced that it has received full payment for the initial $100,000 CDN Purchase Order from Laguna Blends.
As quoted in the press release:

As announced in an earlier news release, the first purchase order from Laguna Blends is for $100,000 CDN. This purchase order is the first installment of a definitive agreement with Laguna Blends to produce $1,600,000 CDN of Pro369, in the first year of the Agreement, and $4,500,000 CDN of Pro369 in the second year of the Agreement. A second Purchase Order of $250,000 CDN is anticipated in the second quarter of 2016.


Naturally Splendid CEO, Craig Goodwin, stated:

I would like to take this opportunity to clarify our agreement with Laguna Blends. There appears to be some confusion from the investment community as to the exclusive rights that Laguna was granted. Laguna does not have exclusive rights to our HempOmega™ technology. The exclusive rights that Naturally Splendid granted Laguna Blends pertains specifically to the four custom protein blends that Naturally Splendid formulated for Laguna Blends only, under the trade name Pro369. Having said that, we are most excited with the upcoming product launch of Laguna Blends.

Connect with Naturally Splendid (TSXV:NSP)  to receive an Investor Presentation.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less